<?xml version="1.0" encoding="UTF-8"?>
<p>A recent study revealed that MTX treatment is probably safe and does not affect the antiviral and inflammatory responses of primary human synovial fibroblasts (HSF). MTX alone did not increase the capacity of CHIKV to infect and replicate in HSF [
 <xref rid="B82-viruses-11-00289" ref-type="bibr">82</xref>]. This fact is important because the immunomodulatory activity of MTX in the context of viral persistence has been of concern.
</p>
